145 related articles for article (PubMed ID: 22210682)
1. Anti-tumor necrosis factor inhibitor therapy-induced dermatomyositis and fasciitis.
Riolo G; Towheed TE
J Rheumatol; 2012 Jan; 39(1):192-4. PubMed ID: 22210682
[No Abstract] [Full Text] [Related]
2. Treatment of spondyloarthritides with anti-TNFalpha biologic agents.
Braun J
Reumatismo; 2006; 58 Spec No.1():71-2. PubMed ID: 23631067
[No Abstract] [Full Text] [Related]
3. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
Nagashima T; Minota S
J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
[No Abstract] [Full Text] [Related]
4. Dermatomyositis during adalimumab therapy for rheumatoid arthritis.
Brunasso AM; Scocco GL; Massone C
J Rheumatol; 2010 Jul; 37(7):1549-50. PubMed ID: 20595297
[No Abstract] [Full Text] [Related]
5. [Cutaneous pseudolymphoma with two types of anti-TNFα: a class effect?].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2012 Oct; 139(10):695-6. PubMed ID: 23122389
[No Abstract] [Full Text] [Related]
6. Dermatomyositis associated with anti-tumor necrosis factor therapy in a patient with psoriasis.
Dicaro D; Bowen C; Dalton SR
J Am Acad Dermatol; 2014 Mar; 70(3):e64-5. PubMed ID: 24528921
[No Abstract] [Full Text] [Related]
7. Systemic Mycobacterium avium complex infection during antitumor necrosis factor-α therapy in pediatric Crohn disease.
Jordan N; Waghmare A; Abi-Ghanem AS; Moon A; Salvatore CM
J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):294-6. PubMed ID: 21694635
[No Abstract] [Full Text] [Related]
8. Evolution of dermatomyositis during therapy with a tumor necrosis factor alpha inhibitor.
Hall HA; Zimmermann B
Arthritis Rheum; 2006 Dec; 55(6):982-4. PubMed ID: 17139649
[No Abstract] [Full Text] [Related]
9. Tumor necrosis factor-α inhibitor-induced antiglomerular basement membrane antibody disease in a patient with rheumatoid arthritis.
Nishimura K; Saegusa J; Kawano S; Morinobu A
J Rheumatol; 2012 Sep; 39(9):1904-5. PubMed ID: 22942311
[No Abstract] [Full Text] [Related]
10. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
van der Stoep D; Braunstahl GJ; van Zeben J; Wouters J
J Rheumatol; 2009 Dec; 36(12):2847-8. PubMed ID: 19966199
[No Abstract] [Full Text] [Related]
11. Switching tumor necrosis factor alpha inhibitors in HLA-B27-associated severe heel enthesitis.
Olivieri I; Scarano E; Padula A; D'angelo S; Cantini F
Arthritis Rheum; 2007 Dec; 57(8):1572-4. PubMed ID: 18050233
[No Abstract] [Full Text] [Related]
12. Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management.
Papadavid E; Gazi S; Dalamaga M; Stavrianeas N; Ntelis V
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):380-2. PubMed ID: 18269613
[No Abstract] [Full Text] [Related]
13. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
14. Anti-TNF-alpha therapies: they are all the same (aren't they?).
Mpofu S; Fatima F; Moots RJ
Rheumatology (Oxford); 2005 Mar; 44(3):271-3. PubMed ID: 15561736
[No Abstract] [Full Text] [Related]
15. [Adalimumab in infliximab refractory Crohn's disease -- the next generation of anti-TNF-alpha-therapy?].
Heidemann J; Kucharzik T
Z Gastroenterol; 2005 Jul; 43(7):689-90. PubMed ID: 16001352
[No Abstract] [Full Text] [Related]
16. Drug-induced lupus erythematosus in a patient treated with adalumimab.
Spillane AP; Xia Y; Sniezek PJ
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S114-6. PubMed ID: 17434034
[No Abstract] [Full Text] [Related]
17. Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
Hyrich KL; Silman AJ
J Rheumatol; 2006 May; 33(5):831-3. PubMed ID: 16652412
[No Abstract] [Full Text] [Related]
18. [Drug-induced systemic lupus erythematosus: reports to The Netherlands Pharmacovigilance Centre Lareb].
van Rijthoven AW; van Roon JA
Ned Tijdschr Geneeskd; 2007 Apr; 151(14):839; author reply 839. PubMed ID: 17469329
[No Abstract] [Full Text] [Related]
19. Adalimumab in juvenile rheumatoid arthritis.
Sfriso P; Ravaioli F
N Engl J Med; 2008 Dec; 359(23):2495; author reply 2496-7. PubMed ID: 19052133
[No Abstract] [Full Text] [Related]
20. Adalimumab in juvenile rheumatoid arthritis.
Taddio A; Marchetti F
N Engl J Med; 2008 Dec; 359(23):2495-6; author reply 2496-7. PubMed ID: 19065749
[No Abstract] [Full Text] [Related]
[Next] [New Search]